Stress-induced analgesia in mice: Evidence for interaction between endocannabinoids and cholecystokinin

European Journal of Neuroscience

Volumn 27, Issue 8, 2008, Pages 2147-2155

  Kurrikoff, Kaido ^a   Inno, Jan ^a   Matsui, Toshimitsu ^b   Vasar, Eero ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cannabinoid; Naloxone; Opioid; Rimonabant; SR141716A; Stress

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CANNABINOID 1 RECEPTOR; CHOLECYSTOKININ; CHOLECYSTOKININ B RECEPTOR; CHOLECYSTOKININ RECEPTOR; ENDOCANNABINOID; LIPOPROTEIN LIPASE; NALOXONE; PHOSPHOLIPASE D; RIMONABANT;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; FOOTSHOCK; GENE EXPRESSION; LIMBIC CORTEX; LUMBAR SPINAL CORD; MALE; MESENCEPHALON; MOUSE; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; STRESS; UPREGULATION;

ANALGESIA; ANIMALS; BRAIN; CHOLECYSTOKININ; ENDOCANNABINOIDS; GENE EXPRESSION; GENE EXPRESSION REGULATION; MICE; MICE, MUTANT STRAINS; NALOXONE; NARCOTIC ANTAGONISTS; PAIN THRESHOLD; PIPERIDINES; PYRAZOLES; RECEPTOR, CHOLECYSTOKININ B; RECEPTORS, CANNABINOID; RECEPTORS, OPIOID; SPINAL CORD; STRESS, PSYCHOLOGICAL;

EID: 42049116945     PISSN: 0953816X     EISSN: 14609568     Source Type: Journal    
DOI: 10.1111/j.1460-9568.2008.06160.x     Document Type: Article

References (33)

1. Akil, H., Young, E., Walker, J.M. Watson, S.J. (1986) The many possible roles of opioids and related peptides in stress-induced analgesia. Ann. N.Y. Acad. Sci., 467, 140 153.
2. Ansah, O.B., Leite-Almeida, H., Wei, H. Pertovaara, A. (2007) Striatal dopamine D2 receptors attenuate neuropathic hypersensitivity in the rat. Exp. Neurol., 205, 536 546.
3. Baber, N.S., Dourish, C.T. Hill, D.R. (1989) The role of CCK caerulein, and CCK antagonists in nociception. Pain, 39, 307 328.
4. Basbaum, A.I. Fields, H.L. (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci., 7, 309 338.
5. Beecher, H.K. (1959) Measurement of Subjective Responses: Quantitative Effects of Drugs. Oxford University Press, New York.
6. Beinfeld, M.C. Connolly, K. (2001) Activation of CB1 cannabinoid receptors in rat hippocampal slices inhibits potassium-evoked cholecystokinin release, a possible mechanism contributing to the spatial memory defects produced by cannabinoids. Neurosci. Lett., 301, 69 71.
7. Faris, P.L., Komisaruk, B.R., Watkins, L.R. Mayer, D.J. (1983) Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science, 219, 310 312.
8. Faris, P.L., McLaughlin, C.L., Baile, C.A., Olney, J.W. Komisaruk, B.R. (1984) Morphine analgesia potentiated but tolerance not affected by active immunization against cholecystokinin. Science, 226, 1215 1217.
9. Fride, E. (2005) Endocannabinoids in the central nervous system: from neuronal networks to behavior. Curr. Drug Targets, 4, 633 642.
10. Gall, C., Lauterborn, J., Burks, D. Seroogy, K. (1987) Co-localization of enkephalin and cholecystokinin in discrete areas of rat brain. Brain Res., 403, 403 408.
11. Hohmann, A.G. (2002) Spinal and peripheral mechanisms of cannabinoid antinociception: behavioral, neurophysiological and neuroanatomical perspectives. Chem. Phys. Lipids, 121, 173 190.
12. Hohmann, A.G., Suplita, R.L., Bolton, N.M., Neely, M.H., Fegley, D., Mangieri, R., Krey, J.F., Walker, J.M., Holmes, P.V., Crystal, J.D., Duranti, A., Tontini, A., Mor, M., Tarzia, G. Piomelli, D. (2005) An endocannabinoid mechanism for stress-induced analgesia. Nature, 435, 1108 1112.
13. Kurrikoff, K., Koks, S., Matsui, T., Bourin, M., Arend, A., Aunapuu, M. Vasar, E. (2004) Deletion of the CCK2 receptor gene reduces mechanical sensitivity and abolishes the development of hyperalgesia in mononeuropathic mice. Eur. J. Neurosci., 20, 1577 1586.
14. Lewis, J.W., Cannon, J.T. Liebeskind, J.C. (1980) Opioid and nonopioid mechanisms of stress analgesia. Science, 208, 623 625.
15. Marchand, F., Ardid, D., Chapuy, E., Alloui, A., Jourdan, D. Eschalier, A. (2003) Evidence for an involvement of supraspinal delta- and spinal mu-opioid receptors in the antihyperalgesic effect of chronically administered clomipramine in mononeuropathic rats. J. Pharmacol. Exp. Ther., 307, 268 274.
16. Marsicano, G. Lutz, B. (1999) Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain. Eur. J. Neurosci., 11, 4213 4225.
17. Nagata, A., Ito, M., Iwata, N., Kuno, J., Takano, H., Minowa, O., Chihara, K., Matsui, T. Noda, T. (1996) G protein-coupled cholecystokinin-B/ gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo. Proc. Natl Acad. Sci. U.S.A., 93, 11 825 11 830.
18. Noble, F. Roques, B.P. (1999) CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology. Prog. Neurobiol., 58, 349 379.
19. Ozaki, S., Narita, M., Narita, M., Iino, M., Sugita, J., Matsumura, Y. Suzuki, T. (2002) Suppression of the morphine-induced rewarding effect in the rat with neuropathic pain: implication of the reduction in mu-opioid receptor functions in the ventral tegmental area. J. Neurochem., 82, 1192 1198.
20. Pohl, M., Benoliel, J.J., Bourgoin, S., Lombard, M.C., Mauborgne, A., Taquet, H., Carayon, A., Besson, J.M., Cesselin, F. Hamon, M. (1990) Regional distribution of calcitonin gene-related peptide-, substance P-, cholecystokinin-, Met5-enkephalin-, and dynorphin A (1-8)-like materials in the spinal cord and dorsal root ganglia of adult rats: effects of dorsal rhizotomy and neonatal capsaicin. J. Neurochem., 55, 1122 1130.
21. Pommier, B., Beslot, F., Simon, A., Pophillat, M., Matsui, T., Dauge, V., Roques, B.P. Noble, F. (2002) Deletion of CCK2 receptor in mice results in an upregulation of the endogenous opioid system. J. Neurosci., 22, 2005 2011.
22. Runkorg, K., Veraksits, A., Kurrikoff, K., Luuk, H., Raud, S., Abramov, U., Matsui, T., Bourin, M., Koks, S. Vasar, E. (2003) Distinct changes in the behavioural effects of morphine and naloxone in CCK2 receptor-deficient mice. Behav. Brain Res., 144, 125 135.
23. Spanagel, R., Herz, A. Shippenberg, T.S. (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc. Natl Acad. Sci. U.S.A., 89, 2046 2050.
24. Stanfa, L., Dickenson, A., Xu, X.J. Wiesenfeld-Hallin, Z. (1994) Cholecystokinin and morphine analgesia: variations on a theme. Trends Pharmacol. Sci., 15, 65 66.
25. Sugiura, T. Waku, K. (2000) 2-Arachidonoylglycerol and the cannabinoid receptors. Chem. Phys. Lipids, 108, 89 106.
26. Suplita, R.L. 2nd, Gutierrez, T., Fegley, D., Piomelli, D. Hohmann, A.G. (2006) Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia. Neuropharmacology, 50, 372 379.
27. Terman, G.W., Lewis, J.W. Liebeskind, J.C. (1986a) Two opioid forms of stress analgesia: studies of tolerance and cross-tolerance. Brain Res., 368, 101 106.
28. Terman, G.W., Morgan, M.J. Liebeskind, J.C. (1986b) Opioid and non-opioid stress analgesia from cold water swim: importance of stress severity. Brain Res., 372, 167 171.
29. Valverde, O., Ledent, C., Beslot, F., Parmentier, M. Roques, B.P. (2000) Reduction of stress-induced analgesia but not of exogenous opioid effects in mice lacking CB1 receptors. Eur. J. Neurosci., 12, 533 539.
30. Veraksits, A., Runkorg, K., Kurrikoff, K., Raud, S., Abramov, U., Matsui, T., Bourin, M., Koks, S. Vasar, E. (2003) Altered pain sensitivity and morphine-induced anti-nociception in mice lacking CCK2 receptors. Psychopharmacology, 166, 168 175.
31. Walker, J.M. Hohmann, A.G. (2005) Cannabinoid mechanisms of pain suppression. In Handbook of Experimental Pharmacology. Springer, Berlin, pp. 509 554.
32. Walker, J.M., Hohmann, A.G., Martin, W.J., Strangman, N.M., Huang, S.M. Tsou, K. (1999) The neurobiology of cannabinoid analgesia. Life Sci., 65, 665 673.
33. Wiesenfeld-Hallin, Z., de Arauja Lucas, G., Alster, P., Xu, X.J. Hokfelt, T. (1999) Cholecystokinin/opioid interactions. Brain Res., 848, 78 89.